Nektar Therapeutics | NKTR - Trade Creditors


Nektar Therapeutics reported $10.03M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 2.86B 16.65B Jun/2026
Baxter International USD 1.03B 52M Jun/2026
BioCryst Pharmaceuticals USD 11.46M 501K Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Cipla INR 32.3B 1.95B Mar/2026
Dr.Reddys Laboratories INR 37.5B 7.12B Jun/2026
Eisai JPY 87.53B 11.64B Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Exelixis USD 39.06M 14.91M Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Incyte USD 1.39B 1.16B Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
MacroGenics USD 3.44M 845K Jun/2026
Merck USD 3.83B 36M Jun/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Takeda JPY 446.78B 44.56B Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026